miR122-controlled all-in-one nanoplatform for in situ theranostic of drug-induced liver injury by visualization imaging guided on-demand drug release

Drug-induced liver injury (DILI) is a challenging clinical problem with respect to both diagnosis and management. As a newly emerging biomarker of liver injury, miR122 shows great potential in early and sensitive in situ detection of DILI. Glycyrrhetinic acid (GA) possesses desirable therapeutic eff...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lingchang Meng, Qiaolei Wang, Lai Wang, Zhen Zhao, Gui-Zhong Xin, Zuguo Zheng, Ping Zhou, Ping Li, Yan Jiang, Hui-Jun Li
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/9f5f733cc6914f77b87c7c4ef60d5273
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!